Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Boston Scientific
(NY:
BSX
)
90.03
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Jan 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Boston Scientific
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Boston Scientific Stock Jumps On Q1 Earnings Beat, Improved Guidance
↗
April 28, 2021
Boston Scientific Corporation (NYSE: BSX) Q1 sales grew by 5.9% (organically) to $2.75 billion, beating the previous guidance range between negative...
Via
Benzinga
Topics
Earnings
Boston Scientific Corp (BSX) Q1 2021 Earnings Call Transcript
↗
April 28, 2021
BSX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
↗
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Stocks That Hit 52-Week Highs On Friday
↗
April 23, 2021
On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:...
Via
Benzinga
Boston Scientific: Q1 Earnings Insights
↗
April 28, 2021
Shares of Boston Scientific (NYSE:BSX) moved higher by 2.9% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 32....
Via
Benzinga
Boston Scientific Earnings Beat, Guidance Raised; BSX Clears Buy Point
↗
April 28, 2021
Boston Scientific earnings beat views, with the medical products giant also raising full-year EPS guidance. BSX stock rose back into a buy zone.
Via
Investor's Business Daily
Topics
Earnings
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
↗
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
↗
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Cramer Gives His Opinion On Snap, Cleveland-Cliffs And More
↗
April 22, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Snap Inc (NYSE: SNAP) is going to have a great quarter. It has tremendous growth and Cramer is a buyer. Regal...
Via
Benzinga
BOSTON SCIENTIFIC INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Boston Scientific Corporation - BSX
April 16, 2021
From
Kahn Swick & Foti, LLC
Via
Business Wire
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
↗
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
'Halftime Report' Final Trades: Apple, Nvidia And More
↗
April 15, 2021
On CNBC's 'Fast Money Halftime Report,' the investment committee gave their final trades of the day. Sand Hill Global Advisors’ Brenda Vingiello likes Apple Inc...
Via
Benzinga
Return On Capital Employed Overview: Boston Scientific
↗
April 15, 2021
Boston Scientific (NYSE:BSX) posted a 124.76% decrease in earnings from Q3. Sales, however, increased by 1.84% over the previous quarter to $2.71 billion. Despite the increase in...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
↗
April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings...
Via
Benzinga
Stocks And ETFs To Buy Now - Sunday, April 11
↗
April 11, 2021
This video discusses which stocks and ETFs to look at for the coming week. This video also discusses cash flow and options strategies.
Via
Talk Markets
These Lower Highs
↗
April 07, 2021
Here are eight charts that have exhibited a series of “lower highs”, which is indicative of trend change.
Via
Talk Markets
< Previous
1
2
...
16
17
18
19
20
21
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.